20/20 Biolabs, Inc. (AIDX) stock
Close on Nov 12, 2026Market cap $2.60MP/E –Yield –
20/20 Biolabs statistics
65 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 1.84
- 5.78
Enterprise valuationIndustry
- EV / Sales
- -0.95
- 1.66
Share statisticsIndustry
- Shares Change (YoY)
- 2.70%
- 1.02%
- Shares Change (QoQ)
- 17.3%
- 0.00%
- Float
- 11M
- 29M
- Shares Held by Insiders
- 14.8%
- 4.27%
- Shares Held by Institutions
- 4.23%
- 67.7%
Short sellingIndustry
- Short Interest
- 57,001
- –
- Short Interest Change
- 405.8%
- -4.60%
- Short % of Float
- 0.52%
- 5.23%
- Short % of Shares Outstanding
- 0.45%
- 3.31%
- Days to Cover
- 1.00
- 4.22
Stock price statisticsIndustry
- 20-Day Moving Average
- $0.23
- –
- 50-Day Moving Average
- $0.36
- –
- Average True Range (14)
- $0.03
- –
- Price Change (1 Week)
- 9.04%
- 0.30%
- Price Change (1 Month)
- -34.9%
- -2.01%
- Price Change (3 Months)
- -62.9%
- -4.18%
- Price Change (6 Months)
- -85.2%
- 0.09%
- Average Volume (10 Days)
- 346,994
- –
- Average Volume (20 Days)
- 249,904
- –
- Average Volume (90 Days)
- 132,873
- –
- Relative Volume
- 1.89
- 0.68
- Relative Strength Index (14)
- 34.8
- 45.5
- Volatility (1 Year)
- 128.6%
- 62.9%
MarginsIndustry
- EBITDA Margin
- -159.8%
- 3.79%
Returns on capitalIndustry
- Return on Equity (ROE)
- -379.1%
- 1.76%
- Return on Assets (ROA)
- -61.1%
- -2.60%
- Return on Capital Employed (ROCE)
- -93.3%
- 3.71%
Financial positionIndustry
- Current Ratio
- 1.99
- 1.36
- Quick Ratio
- 1.90
- 0.75
- Interest Coverage
- -21.32
- -0.21
GrowthIndustry
- Revenue Growth (YoY)
- 16.7%
- 5.34%
EfficiencyIndustry
- Asset Turnover
- 0.33
- 0.82
- Inventory Turnover
- 12.97
- 12.46
- Revenue Per Employee
- $146.08K
- $215.67K
- Profits Per Employee
- -$267.06K
- -$534
- Employee Count
- 14
- 99
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $4.55M
- $10.79K
- Net Cash Per Share
- $0.36
- $0.00
- Equity (Book Value)
- $1.62M
- $12.47M
- Book Value Per Share
- $0.13
- $0.73
- Tangible Book Value
- $1.41M
- $13.82K
- Working Capital
- $2.52M
- $4.10M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- -143.7%
- 0.80%
Taxes and interestIndustry
- Interest Expense
- $156.21K
- $468.43K
Scores and fair valueIndustry
- Altman Z-Score
- -8.88
- 2.98
- Piotroski F-Score
- 5
- 5
- Beneish M-Score
- -4.20
- -2.75
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | AIDX | S&P 500 | Difference | AIDX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -44.3% | -2.7% | −41.6 pts | ||
| 3 months | -55.8% | -1.7% | −54.0 pts |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M AIDX shares were sold short on Oct 30, 2026, up 405.8% from the previous report, or 0.52% of the shares available to trade. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 40.0% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 57,001 | +405.8% | 160,271 | 1.0 |
| Oct 15, 2026 | 11,270 | -75.0% | 131,753 | 1.0 |
| Sep 30, 2026 | 45,167 | -3.5% | 52,472 | 1.0 |
| Sep 15, 2026 | 46,806 | -50.4% | 58,991 | 1.0 |
| Aug 31, 2026 | 94,280 | -10.9% | 100,240 | 1.0 |
| Aug 14, 2026 | 105,841 | -31.0% | 100,697 | 1.1 |
| Jul 31, 2026 | 153,293 | -38.3% | 118,274 | 1.3 |
| Jul 15, 2026 | 248,647 | +33.1% | 342,800 | 1.0 |
| Jun 30, 2026 | 186,863 | -36.0% | 424,508 | 1.0 |
| Jun 15, 2026 | 291,990 | +126.7% | 2,692,121 | 1.0 |
| May 29, 2026 | 128,775 | +613.4% | 1,125,074 | 1.0 |
| May 15, 2026 | 18,050 | -45.5% | 70,768 | 1.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?